Rimon

California Outlaws Historic Ability of Employers from Requiring PTO Leave before PFL Leave

Insights California Outlaws Historic Ability of Employers from Requiring PTO Leave before PFL Leave Robert H. Pepple · California Outlaws Historic Ability of Employers from Requiring PTO Leave before PFL Leave Christopher J. Kelly · March 11, 2025

Effective January 1, 2025, California employers can no longer require employees to use accrued vacation or PTO before receiving state-funded Paid Family Leave (PFL) benefits. This update, made through an amendment to Section 3303.1 of the Unemployment Insurance Code (UIC), reflects a small but meaningful shift in how PFL benefits are administered. Many HR teams and…

Continue Reading…

Rimon Recognized as a Pinnacle Performing Law Firm in the 2024 Leopard Law Firm Index

Awards March 6, 2025

Rimon, P.C. is honored to be recognized as a top-performing law firm in the 2024 Leopard Law Firm Index, an innovative real-time ranking system developed by Leopard Solutions. This recognition underscores Rimon’s commitment to excellence, growth, and continued success in the legal industry. The Leopard Law Firm Index evaluates law firms based on key performance…

Continue Reading…

Neuphoria Therapeutics Ring the Nasdaq Opening Bell

News Neuphoria Therapeutics Ring the Nasdaq Opening Bell Theodore (Ted) Ghorra · Neuphoria Therapeutics Ring the Nasdaq Opening Bell Andrew Reilly · Neuphoria Therapeutics Ring the Nasdaq Opening Bell Elaine Wangsawidjaja · Neuphoria Therapeutics Ring the Nasdaq Opening Bell Olivia Y. Wang · March 6, 2025

We congratulate our client, Neuphoria Therapeutics Inc. on their successful redomiciliation to the U.S. In celebratory fashion, Neuphoria Therapeutics Inc. rang the Nasdaq Opening Bell on March 3rd, 2025!  Ted Ghorra, Andrew Reilly, Elaine Wangsawidjaja and Olivia Wang have worked regularly with this client. Read more here Rimon’s Securities and Capital Markets attorneys have decades…

Continue Reading…

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

News Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership Debbie A. Klis · Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership Mark C. Lee · Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership Olivia Y. Wang · March 5, 2025

Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicines,  announced a change in control and leadership on February 26, 2025. Datuk Dr. Doris Wong Sing Ee acquired the majority interest in Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) and will now serve as its Chief Executive Officer and Executive Director. In…

Continue Reading…

Now You See It: Waetzig v. Halliburton and the Lawsuit That Wouldn’t Stay Gone

Insights Now You See It: Waetzig v. Halliburton and the Lawsuit That Wouldn’t Stay Gone Robert H. Pepple · March 4, 2025

A magician’s fake thumb hides an object. The audience believes it’s vanished, but it’s still there, waiting. A voluntary dismissal works the same way—for a while. The lawsuit disappears from the docket. The defendant relaxes. The case is gone. Until it isn’t. In Waetzig v. Halliburton Energy Services, Inc., 604 U.S. ___ (2025), the Supreme Court…

Continue Reading…

Review on the 16th EU Package of Sanctions Against Russia

Insights Review on the 16th EU Package of Sanctions Against Russia Stephanie De Giovanni · Review on the 16th EU Package of Sanctions Against Russia Elia El Kouh · March 3, 2025

While President Trump is trying to achieve a peace agreement with Russia regarding Ukraine through “muscular diplomacy”, French President Emmanuel Macron, who spoke on behalf of the EU at a joint press conference on 24 February 2025 at the White House, stressed the need to provide “security guarantees” to Ukraine. In parallel, the European Council…

Continue Reading…

Rimon Partner Héctor Arangua Ranked by Chambers Global 2025 for Capital Markets – Mexico

Awards Rimon Partner Héctor Arangua Ranked by Chambers Global 2025 for Capital Markets – Mexico Hector Arangua · February 26, 2025

Rimon P.C. is proud to announce that Héctor Arangua has been recognized in the Chambers Global 2025 for Capital Markets – Mexico rankings. Chamber methodology: Chambers is the ranking that matters. It is underpinned by a research methodology unrivalled in accuracy, depth and quality. The only process that delivers rankings, insights and actionable business intelligence…

Continue Reading…

Arogo Capital Acquisition Corp announces business combination agreement with Bangkok Tellink Co., Ltd. valued at $350 million

News Arogo Capital Acquisition Corp announces business combination agreement with Bangkok Tellink Co., Ltd. valued at $350 million Debbie A. Klis · Arogo Capital Acquisition Corp announces business combination agreement with Bangkok Tellink Co., Ltd. valued at $350 million Ivan Komaritsky · Arogo Capital Acquisition Corp announces business combination agreement with Bangkok Tellink Co., Ltd. valued at $350 million Benjamin Aguilera · Arogo Capital Acquisition Corp announces business combination agreement with Bangkok Tellink Co., Ltd. valued at $350 million Roy W. Gillig · Arogo Capital Acquisition Corp announces business combination agreement with Bangkok Tellink Co., Ltd. valued at $350 million Olivia Y. Wang · February 20, 2025

Rimon SPAC client  Arogo Capital Acquisition Corp., announced that it has executed a business combination agreement with Bangkok Tellink Co., Ltd. Bangkok Tellink Co., Ltd. is an emerging leader in advanced telecommunications, mobile network technology, and Internet of Things (IoT) solutions. The transaction is estimated to be valued at USD$350 million and is expected to result…

Continue Reading…

Congratulations to Swati Samanth on Her Promotion to Counsel

News Congratulations to Swati Samanth on Her Promotion to Counsel Swati Samanth · February 19, 2025

We’re excited to announce the promotion of Swati Samanth to Counsel. Her commitment and expertise have been integral to Rimon’s team, and we look forward to seeing her thrive in this new role. Congratulations, Swati! Swati Samanth is an associate in Rimon’s San Francisco office where her practice focuses on Intellectual Property. She brings over…

Continue Reading…

RIMON – TSBD Joint Seminar: Japan-US Innovation 2025

Events RIMON – TSBD Joint Seminar: Japan-US Innovation 2025 Eric D. Kirsch · RIMON – TSBD Joint Seminar: Japan-US Innovation 2025 Sandra Lee Bell · RIMON – TSBD Joint Seminar: Japan-US Innovation 2025 Ivan Komaritsky · RIMON – TSBD Joint Seminar: Japan-US Innovation 2025 Mi-Yong Kim · Friday, March 7th, 2025, 9:30AM – 12:00AM

Japan-US Innovation 2025: Cross Border Innovation, Collaboration and Regulation in the New Trump Era The new Trump administration promises drastic changes in Gobal trade initiatives which will affect Japanese companies that are working closely with companies in the U.S. and Japanese companies that import products into the U.S. In this seminar, you will hear from…

Continue Reading…